Search

Jon E. Angell

Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1635, 1637, 1674
Total Applications
1431
Issued Applications
721
Pending Applications
199
Abandoned Applications
530

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6576555 [patent_doc_number] => 20100129491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Tryptophan transporter gene and use thereof' [patent_app_type] => utility [patent_app_number] => 11/991162 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7942 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129491.pdf [firstpage_image] =>[orig_patent_app_number] => 11991162 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/991162
Tryptophan transporter gene and use thereof Aug 30, 2006 Abandoned
Array ( [id] => 4485692 [patent_doc_number] => 07902352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Isolated nucleic acid duplex for reducing huntington gene expression' [patent_app_type] => utility [patent_app_number] => 11/501634 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 32 [patent_no_of_words] => 14653 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902352.pdf [firstpage_image] =>[orig_patent_app_number] => 11501634 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/501634
Isolated nucleic acid duplex for reducing huntington gene expression Aug 8, 2006 Issued
Array ( [id] => 4485692 [patent_doc_number] => 07902352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Isolated nucleic acid duplex for reducing huntington gene expression' [patent_app_type] => utility [patent_app_number] => 11/501634 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 32 [patent_no_of_words] => 14653 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902352.pdf [firstpage_image] =>[orig_patent_app_number] => 11501634 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/501634
Isolated nucleic acid duplex for reducing huntington gene expression Aug 8, 2006 Issued
Array ( [id] => 8017315 [patent_doc_number] => 08138160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Reagents, methods and systems to suppress pro-inflammatory cytokines' [patent_app_type] => utility [patent_app_number] => 11/498649 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6850 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/138/08138160.pdf [firstpage_image] =>[orig_patent_app_number] => 11498649 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/498649
Reagents, methods and systems to suppress pro-inflammatory cytokines Aug 2, 2006 Issued
Array ( [id] => 6623282 [patent_doc_number] => 20100003753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Multivalent rna nanoparticles for delivery of active agents to a cell' [patent_app_type] => utility [patent_app_number] => 11/989590 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 48729 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003753.pdf [firstpage_image] =>[orig_patent_app_number] => 11989590 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/989590
Multivalent rna nanoparticles for delivery of active agents to a cell Jul 31, 2006 Abandoned
Array ( [id] => 4971226 [patent_doc_number] => 20070111228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'RNA interference' [patent_app_type] => utility [patent_app_number] => 11/496966 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 30767 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111228.pdf [firstpage_image] =>[orig_patent_app_number] => 11496966 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/496966
RNA interference Jul 30, 2006 Abandoned
Array ( [id] => 5204955 [patent_doc_number] => 20070026436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'GLUCOSE TRANSPORT-RELATED GENES, POLYPEPTIDES, AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/460102 [patent_app_country] => US [patent_app_date] => 2006-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16155 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026436.pdf [firstpage_image] =>[orig_patent_app_number] => 11460102 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/460102
GLUCOSE TRANSPORT-RELATED GENES, POLYPEPTIDES, AND METHODS OF USE THEREOF Jul 25, 2006 Abandoned
Array ( [id] => 4899812 [patent_doc_number] => 20080119426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Compositions and methods for the treatment of muscle wasting' [patent_app_type] => utility [patent_app_number] => 11/479112 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22879 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119426.pdf [firstpage_image] =>[orig_patent_app_number] => 11479112 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/479112
Compositions and methods for the treatment of muscle wasting Jun 29, 2006 Issued
Array ( [id] => 5928963 [patent_doc_number] => 20110038922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'COMPOUNDS FOR TREATING OR PREVENTING AMINE OXIDASE RELATED DISEASES OR DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/917638 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5329 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038922.pdf [firstpage_image] =>[orig_patent_app_number] => 11917638 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/917638
COMPOUNDS FOR TREATING OR PREVENTING AMINE OXIDASE RELATED DISEASES OR DISORDERS Jun 11, 2006 Abandoned
Array ( [id] => 5391187 [patent_doc_number] => 20090208500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Method of producing antibodies with improved function' [patent_app_type] => utility [patent_app_number] => 11/447506 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 34714 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208500.pdf [firstpage_image] =>[orig_patent_app_number] => 11447506 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/447506
Method of producing antibodies with improved function Jun 4, 2006 Abandoned
Array ( [id] => 4820310 [patent_doc_number] => 20080226601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods' [patent_app_type] => utility [patent_app_number] => 11/916434 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33411 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226601.pdf [firstpage_image] =>[orig_patent_app_number] => 11916434 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/916434
Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods Jun 4, 2006 Abandoned
Array ( [id] => 12509910 [patent_doc_number] => 10000757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => Gene vector [patent_app_type] => utility [patent_app_number] => 11/921140 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 22787 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11921140 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/921140
Gene vector May 25, 2006 Issued
Array ( [id] => 5141393 [patent_doc_number] => 20070003609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Vectorization of dsRNA by cationic particles and topical use' [patent_app_type] => utility [patent_app_number] => 11/436515 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13181 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003609.pdf [firstpage_image] =>[orig_patent_app_number] => 11436515 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/436515
Vectorization of dsRNA by cationic particles and topical use May 18, 2006 Issued
Array ( [id] => 10056290 [patent_doc_number] => 09095630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Vectorization of dsRNA by cationic particles and use of same on a skin model' [patent_app_type] => utility [patent_app_number] => 11/436775 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 13860 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11436775 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/436775
Vectorization of dsRNA by cationic particles and use of same on a skin model May 18, 2006 Issued
Array ( [id] => 6597829 [patent_doc_number] => 20100048678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Nucleic acids and polypeptides that are useful in controlling neuronal regeneration' [patent_app_type] => utility [patent_app_number] => 11/920721 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22360 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048678.pdf [firstpage_image] =>[orig_patent_app_number] => 11920721 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/920721
Nucleic acids and polypeptides that are useful in controlling neuronal regeneration May 17, 2006 Abandoned
Array ( [id] => 5480033 [patent_doc_number] => 20090202990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'METHODS FOR THE SELECTION OF APTAMERS' [patent_app_type] => utility [patent_app_number] => 11/916776 [patent_app_country] => US [patent_app_date] => 2006-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10991 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202990.pdf [firstpage_image] =>[orig_patent_app_number] => 11916776 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/916776
Methods for the selection of aptamers May 15, 2006 Issued
Array ( [id] => 5220277 [patent_doc_number] => 20070161588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Modulating cancer cell characteristics' [patent_app_type] => utility [patent_app_number] => 11/436962 [patent_app_country] => US [patent_app_date] => 2006-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3782 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161588.pdf [firstpage_image] =>[orig_patent_app_number] => 11436962 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/436962
Modulating cancer cell characteristics May 15, 2006 Issued
Array ( [id] => 5046540 [patent_doc_number] => 20070265214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Antisense antiviral agent and method for treating ssRNA viral infection' [patent_app_type] => utility [patent_app_number] => 11/431968 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15369 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265214.pdf [firstpage_image] =>[orig_patent_app_number] => 11431968 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/431968
Antisense antiviral agent and method for treating ssRNA viral infection May 9, 2006 Issued
Array ( [id] => 5732795 [patent_doc_number] => 20060257912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods and sequences to suppress primate huntington gene expression' [patent_app_type] => utility [patent_app_number] => 11/429491 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13804 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257912.pdf [firstpage_image] =>[orig_patent_app_number] => 11429491 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/429491
Methods and sequences to suppress primate huntington gene expression May 3, 2006 Abandoned
Array ( [id] => 5242159 [patent_doc_number] => 20070020652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Methods and compositions for RNA interference' [patent_app_type] => utility [patent_app_number] => 11/413795 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20298 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020652.pdf [firstpage_image] =>[orig_patent_app_number] => 11413795 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/413795
Methods and compositions for RNA interference Apr 27, 2006 Abandoned
Menu